April 2024
1. MCCURDY H, Nobbe A, Scott D, Patton H, et al
   Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
   Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
   

   >> Share

   
   
2. PEARLMAN BL
   Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
   Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
   

   >> Share

   
   
3. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
   Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
   Dig Dis Sci. 2024;69:1430-1443.
   

   >> Share

   
   
4. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
   Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Dig Dis Sci. 2024;69:1444-1453.
   

   >> Share

   
   
5. BEHARI J
   Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
   Dig Dis Sci. 2024;69:1093-1095.
   

   >> Share

   
   March 2024
6. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
   Hospital-Level Care at Home for Patients with Cirrhosis.
   Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
   

   >> Share

   
   
7. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
   Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
   Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
   

   >> Share

   
   
8. PATEL AA, Walling A, Bansal A
   A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
   Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
   

   >> Share

   
   
9. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
   Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
   Dig Dis Sci. 2024;69:989-1003.
   

   >> Share

   
   February 2024
10. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    

    >> Share

    
    
11. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    

    >> Share

    
    
12. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    

    >> Share

    
    
13. LI R, Sarin S
    Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
    Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
    

    >> Share

    
    
14. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    

    >> Share

    
    
15. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    

    >> Share

    
    January 2024
16. ASADA S, Namisaki T, Kaji K, Takaya H, et al
    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
    Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
    

    >> Share

    
    
17. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
    A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
    

    >> Share

    
    
18. TSAI SY, O'Leary JG
    Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
    

    >> Share

    
    
19. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
    Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
    

    >> Share

    
    
20. BLOOM PP, Che Z, Hyde A, Johnson E, et al
    Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
    

    >> Share

    
    December 2023
21. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    

    >> Share

    
    
22. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    

    >> Share

    
    November 2023
23. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    

    >> Share

    
    
24. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    

    >> Share

    
    
25. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    

    >> Share

    
    October 2023
26. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    

    >> Share

    
    
27. GONZALEZ HC, Trudeau S
    COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
    

    >> Share

    
    
28. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
    Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
    

    >> Share

    
    
29. BANGARU S, Sundaresh R, Lee A, Prause N, et al
    Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
    

    >> Share

    
    
30. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
    Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
    

    >> Share

    
    
31. LI R, Li M, Bidulescu A, Fly AD, et al
    Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
    Dig Dis Sci. 2023;68:4009-4021.
    

    >> Share

    
    September 2023
32. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
    MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
    Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
    

    >> Share

    
    
33. CHOI AY, Li X, Guo W, Chandan VS, et al
    Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3-4 Fibrosis.
    Dig Dis Sci. 2023;68:3774-3780.
    

    >> Share

    
    
34. MCNALLY BB, Rangan P, Wijarnpreecha K, Fallon MB, et al
    Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
    Dig Dis Sci. 2023;68:3765-3773.
    

    >> Share

    
    July 2023
35. TAPPER EB, Saleh ZM, Lizza S, Chen X, et al
    CAREGIVER Randomized Trial of Two Mindfulness Methods to Improve the Burden and Distress of Caring for Persons with Cirrhosis.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08042.
    

    >> Share

    
    
36. SUAREZ M, Martinez R, Torres AM, Torres B, et al
    A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2023 Jul 21. doi: 10.1007/s10620-023-08031.
    

    >> Share

    
    
37. MOORE JA, Wheless WH, Zhang J, Marsden J, et al
    Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2946-2953.
    

    >> Share

    
    
38. BROWN C, Aksan N, Chang P, Jagannathan P, et al
    Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR.
    Dig Dis Sci. 2023;68:2954-2962.
    

    >> Share

    
    June 2023
39. WENTWORTH BJ, Khot R, Caldwell SH
    The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
    Dig Dis Sci. 2023 Jun 26. doi: 10.1007/s10620-023-08003.
    

    >> Share

    
    
40. ATTANASI ML, Bou Daher H, Rockey DC
    Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.
    Dig Dis Sci. 2023 Jun 22. doi: 10.1007/s10620-023-07993.
    

    >> Share

    
    
41. MCHENRY S, Awad A, Kozlitina J, Stitziel NO, et al
    Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07980.
    

    >> Share

    
    
42. BOU DAHER H, Manka P, Syn WK
    Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
    Dig Dis Sci. 2023;68:2217-2220.
    

    >> Share

    
    
43. BERTOT LC, Jeffrey GP, de Boer B, Wang Z, et al
    Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan(R) to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2757-2767.
    

    >> Share

    
    May 2023
44. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07969.
    

    >> Share

    
    
45. KAPLAN DE
    Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07970.
    

    >> Share

    
    
46. MUKUND A, Marri UK, Jindal A, Choudhury A, et al
    Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Dig Dis Sci. 2023 May 12. doi: 10.1007/s10620-023-07930.
    

    >> Share

    
    
47. SANDHU S, John BV
    Spontaneous Bacterial Peritonitis: The Bug Matters.
    Dig Dis Sci. 2023;68:1667-1669.
    

    >> Share

    
    
48. FUREY C, Zhou S, Park JH, Foong A, et al
    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2023;68:2140-2148.
    

    >> Share

    
    April 2023
49. CHOW KW, Ibrahim BM, Yum JJ, Dang A, et al
    Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935.
    

    >> Share

    
    
50. GARG R, Mohammed A, Singh A, Siddiki H, et al
    Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.
    Dig Dis Sci. 2023 Apr 25. doi: 10.1007/s10620-023-07945.
    

    >> Share

    
    
51. WANG CL, Huang CH, Wu VC, Wu CL, et al
    Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C.
    Dig Dis Sci. 2023 Apr 18. doi: 10.1007/s10620-023-07943.
    

    >> Share

    
    
52. PATERNOSTRO R
    Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
    Dig Dis Sci. 2023;68:1089-1090.
    

    >> Share

    
    
53. UNALP-ARIDA A, Ruhl CE
    Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
    Dig Dis Sci. 2023;68:1237-1252.
    

    >> Share

    
    
54. MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
    Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.
    Dig Dis Sci. 2023;68:1632-1640.
    

    >> Share

    
    March 2023
55. PROTOPAPAS AA, Savopoulos C, Skoura L, Goulis I, et al
    Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
    Dig Dis Sci. 2023 Mar 24. doi: 10.1007/s10620-023-07858.
    

    >> Share

    
    
56. SMITH HT, de Souza AR, Thompson AH, McLaughlin MM, et al
    Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Dig Dis Sci. 2023 Mar 18:1-21. doi: 10.1007/s10620-023-07862.
    

    >> Share

    
    
57. KHALIFA A, Obeid JS, Gregoski MJ, Rockey DC, et al
    Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
    Dig Dis Sci. 2023 Mar 10. doi: 10.1007/s10620-023-07876.
    

    >> Share

    
    
58. CALMET FH, Martin P
    Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage.
    Dig Dis Sci. 2023;68:723-724.
    

    >> Share

    
    
59. SINGAL AG, Parikh ND, Hoshida Y
    Precision HCC Surveillance: It Is All in the Number (Needed).
    Dig Dis Sci. 2023;68:720-722.
    

    >> Share

    
    
60. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    

    >> Share

    
    
61. ELHENCE A, Anand A, Biswas S, Vaishnav M, et al
    Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Dig Dis Sci. 2023;68:1016-1025.
    

    >> Share

    
    February 2023
62. DUKEWICH M, Liu CH, Weinberg EM, Mahmud N, et al
    Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis.
    Dig Dis Sci. 2023 Feb 12. doi: 10.1007/s10620-023-07856.
    

    >> Share

    
    
63. ISLAM KB, Brandman D, Chu JN, Goldman ML, et al
    Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Dig Dis Sci. 2023;68:434-438.
    

    >> Share

    
    
64. LV L, Wang D, Yin J, Yang T, et al
    Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
    Dig Dis Sci. 2023;68:487-496.
    

    >> Share

    
    January 2023
65. SONG J, Wang X, Yan Y, Xiang T, et al
    MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2023 Jan 30. doi: 10.1007/s10620-023-07834.
    

    >> Share

    
    
66. DAHMUS J, Hummer B, Rivas G, Schmitz K, et al
    Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
    Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-022-07809.
    

    >> Share

    
    December 2022
67. LI T, Liu J, Zhao J, Bai Y, et al
    Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07806.
    

    >> Share

    
    
68. RUDNICK SR, Ugwuegbu J, Soufleris SJ, Bundy R, et al
    Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07786.
    

    >> Share

    
    
69. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
    Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
    

    >> Share

    
    
70. WANG ZJ, Lv XH, Yang JL
    Methodological Issues to Be Considered in Evaluating Advanced Endoscopic Resection Techniques in Cirrhosis.
    Dig Dis Sci. 2022 Dec 20. doi: 10.1007/s10620-022-07767.
    

    >> Share

    
    
71. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
    Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
    Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
    

    >> Share

    
    November 2022
72. HORVATITS T, Mahmud N, Serper M, Seiz O, et al
    MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07744.
    

    >> Share

    
    
73. CURRAN C, Priest M, Datta S, Forrest EH, et al
    Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
    

    >> Share

    
    
74. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
    Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Dig Dis Sci. 2022;67:5327-5335.
    

    >> Share

    
    
75. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
    Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:5272-5279.
    

    >> Share

    
    October 2022
76. LIU CH, Jiang W, Wu DB, Zeng QM, et al
    Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Oct 13. pii: 10.1007/s10620-022-07695.
    

    >> Share

    
    September 2022
77. KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
    Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
    

    >> Share

    
    
78. SINGH A, De A, Singh MP, Rathi S, et al
    Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
    Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
    

    >> Share

    
    
79. LIU BD, Qureshi K
    Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
    Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07661.
    

    >> Share

    
    
80. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    

    >> Share

    
    August 2022
81. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
    Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
    

    >> Share

    
    
82. CANCADO GGL, Couto CA, Terrabuio DRB, Cancado ELR, et al
    Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
    Dig Dis Sci. 2022 Aug 22. pii: 10.1007/s10620-022-07654.
    

    >> Share

    
    
83. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    

    >> Share

    
    
84. FERREIRA RD, John BV
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    

    >> Share

    
    July 2022
85. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    

    >> Share

    
    
86. MANDORFER M
    Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
    

    >> Share

    
    
87. ADAMS PC
    Hepatocellular Carcinoma in Hemochromatosis: Where or When?
    Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
    

    >> Share

    
    
88. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    

    >> Share

    
    
89. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    

    >> Share

    
    
90. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
    Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3333-3339.
    

    >> Share

    
    June 2022
91. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
    Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
    

    >> Share

    
    
92. MAYO MJ, Carey E, Smith HT, Mospan AR, et al
    Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07581.
    

    >> Share

    
    
93. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    

    >> Share

    
    
94. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    

    >> Share

    
    May 2022
95. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    

    >> Share

    
    
96. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
    

    >> Share

    
    
97. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    

    >> Share

    
    April 2022
98. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    

    >> Share

    
    
99. ZHAO M, Ma L, Honda T, Kato A, et al
    Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
    Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
    

    >> Share

    
    
100. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
     Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
     Dig Dis Sci. 2022;67:1379-1388.
     

     >> Share

     
     March 2022
101. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
     Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
     Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
     

     >> Share

     
     
102. ANIEMEKA C, Pillai AA
     HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
     Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
     

     >> Share

     
     
103. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
     Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
     Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
     

     >> Share

     
     
104. MAK LY, Wong DK, Cheung KS, Hui RW, et al
     Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
     Dig Dis Sci. 2022 Mar 8. pii: 10.1007/s10620-022-07429.
     

     >> Share

     
     
105. SAAB S, Pham N, Wu W, Dang L, et al
     Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naive Chronic Hepatitis B Patients.
     Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07402.
     

     >> Share

     
     February 2022
106. SINGH AD, Ford A, Lyu R, Layoun H, et al
     Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
     Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
     

     >> Share

     
     
107. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
     Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
     Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
     

     >> Share

     
     
108. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
     Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
     Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
     

     >> Share

     
     
109. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
     Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
     Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
     

     >> Share

     
     
110. GIBBS JT, Louissaint J, Tapper EB
     Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
     Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
     

     >> Share

     
     January 2022
111. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
     Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
     Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
     

     >> Share

     
     
112. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
     Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
     Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
     

     >> Share

     
     
113. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
     Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
     Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
     

     >> Share

     
     
114. KHALIFA A, Sasso R, Rockey DC
     Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
     Dig Dis Sci. 2022;67:337-343.
     

     >> Share

     
     December 2021
115. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
     Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
     Dig Dis Sci. 2021;66:4501-4507.
     

     >> Share

     
     November 2021
116. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
     Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
     Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
     

     >> Share

     
     
117. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
     Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
     

     >> Share

     
     
118. BENITEZ C
     Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
     

     >> Share

     
     
119. ABDU B, Akolkar S, Picking C, Boura J, et al
     Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
     Dig Dis Sci. 2021;66:4035-4045.
     

     >> Share

     
     October 2021
120. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
     Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
     Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
     

     >> Share

     
     September 2021
121. LI J, Lu M, Zhou Y, Bowlus CL, et al
     Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
     

     >> Share

     
     
122. CHUN HS, Lee JS, Lee HW, Kim BK, et al
     Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
     Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
     

     >> Share

     
     
123. JEON Y, Limketkai BN
     Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
     Dig Dis Sci. 2021;66:2853-2854.
     

     >> Share

     
     August 2021
124. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
     Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
     Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
     

     >> Share

     
     
125. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
     Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
     Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
     

     >> Share

     
     
126. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
     Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
     

     >> Share

     
     
127. ZHANG S, Tao X, Wang L, Chen H, et al
     Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
     

     >> Share

     
     
128. THAKER S, Mikolajczyk AE
     Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
     

     >> Share

     
     
129. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
     Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
     

     >> Share

     
     July 2021
130. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
     Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
     

     >> Share

     
     
131. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
     Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
     

     >> Share

     
     
132. BOPPANA V, Sahni S, Glass J, Chang C, et al
     HCC You Cannot See.
     Dig Dis Sci. 2021;66:2185-2189.
     

     >> Share

     
     June 2021
133. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
     Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
     

     >> Share

     
     
134. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
     Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
     

     >> Share

     
     
135. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
     Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
     Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
     

     >> Share

     
     
136. FRENETTE CT, Levy C, Saab S
     Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
     Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
     

     >> Share

     
     
137. GELOW K, Chalasani S, Green K, Lammert C, et al
     Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
     Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
     

     >> Share

     
     
138. HA NB, Cho SJ, Mohamad Y, Kent D, et al
     Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
     

     >> Share

     
     
139. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
     International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
     Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
     

     >> Share

     
     May 2021
140. PENG X, Tian A, Li J, Mao Y, et al
     Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
     Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
     

     >> Share

     
     
141. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
     Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
     Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
     

     >> Share

     
     
142. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
     Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
     Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
     

     >> Share

     
     
143. SERPER M
     Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
     

     >> Share

     
     
144. LIN MH, Li HQ, Zhu L, Su HY, et al
     Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
     

     >> Share

     
     
145. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
     A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
     Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
     

     >> Share

     
     April 2021
146. TROWELL J, Alukal J, Zhang T, Liu L, et al
     How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
     Dig Dis Sci. 2021;66:1297-1305.
     

     >> Share

     
     March 2021
147. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
     Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
     

     >> Share

     
     February 2021
148. JONES BE, Allegretti AS, Pose E, Mara KC, et al
     Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
     Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
     

     >> Share

     
     
149. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
     Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
     Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
     

     >> Share

     
     January 2021
150. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
     CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
     Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
     

     >> Share

     
     
151. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
     Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
     

     >> Share

     
     November 2020
152. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
     Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
     Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
     

     >> Share

     
     
153. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
     Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
     Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
     

     >> Share

     
     
154. ABY ES, Pham NV, Yum JJ, Dong TS, et al
     Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
     Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
     

     >> Share

     
     
155. CHEN HW, Ferrando A, White MG, Dennis RA, et al
     Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
     Dig Dis Sci. 2020;65:3350-3359.
     

     >> Share

     
     October 2020
156. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
     Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
     Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
     

     >> Share

     
     September 2020
157. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
     Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
     Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
     

     >> Share

     
     
158. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
     Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
     Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
     

     >> Share

     
     
159. PATEL A, Asch S, Antonio AL, Kanwal F, et al
     Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
     Dig Dis Sci. 2020;65:2562-2570.
     

     >> Share

     
     August 2020
160. DENG LX, Mehta N
     Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
     Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
     

     >> Share

     
     
161. PHAW NA, Dyson JK, Mells G, Jones D, et al
     Understanding Fatigue in Primary Biliary Cholangitis.
     Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
     

     >> Share

     
     
162. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
     Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
     Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
     

     >> Share

     
     
163. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
     High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
     Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
     

     >> Share

     
     
164. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
     Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
     Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
     

     >> Share

     
     
165. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
     External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
     Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
     

     >> Share

     
     
166. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
     Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
     

     >> Share

     
     July 2020
167. LE L, Kullar R, Saleh HM, Saab S, et al
     Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
     Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
     

     >> Share

     
     
168. XIE X, Dou CY, Zhou Y, Zhou Q, et al
     MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
     Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
     

     >> Share

     
     June 2020
169. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
     Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
     

     >> Share

     
     May 2020
170. SHROFF H, Rinella ME
     Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
     Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
     

     >> Share

     
     April 2020
171. ACHARYA C, White MB, Fagan A, Sterling RK, et al
     Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
     Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
     

     >> Share

     
     
172. TESTINO G
     Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
     Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
     

     >> Share

     
     
173. O'BEIRNE J
     Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
     Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.
     

     >> Share

     
     March 2020
174. LI J, Dong S, Ye M, Peng G, et al
     MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
     Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
     

     >> Share

     
     February 2020
175. MELLINGER JL, Stine JG
     Early Liver Transplantation for Severe Alcoholic Hepatitis.
     Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
     

     >> Share

     
     
176. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
     A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
     Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
     

     >> Share

     
     January 2020
177. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
     Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
     Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
     

     >> Share

     
     
178. ENOMOTO M, Kawada N
     The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
     Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
     

     >> Share

     
     December 2019
179. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
     Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
     Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
     

     >> Share

     
     
180. KAPS L, Grambihler A, Yemane B, Nagel M, et al
     Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
     Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
     

     >> Share

     
     November 2019
181. CHEN Y, Ji H, Shao J, Jia Y, et al
     Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
     Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
     

     >> Share

     
     
182. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
     Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
     Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
     

     >> Share

     
     October 2019
183. HUANG R, Rao H, Yang M, Gao Y, et al
     Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
     Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share